SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Estimated research and development costs of rotavirus vaccines
7 references·1 citing·20 second hop
Estimated research and development costs of rotavirus vaccines (2009)Estimated research and development costs …The cost of biopharmaceutical R&D: is biotech different? (2007)The cost of biopharmaceutical…Are Development Times For Pharmaceuticals Increasing Or Decreasing? (2006)Are Development Times For Pha…The $800 million pill: the truth behind the cost of new drugs (2005)The $800 million pill: the tr…Extraordinary claims require extraordinary evidence (2005)Extraordinary claims require …The price of innovation: new estimates of drug development costs (2003)The price of innovation: new …Cost of innovation in the pharmaceutical industry (1991)Cost of innovation in the pha…Issues in Pharmaceutical Economics (1980)Issues in Pharmaceutical Econ…Estimating the Cost of Industry Investment in Drug Research and Development: A Review of Methods and Results (2021)Estimating the Cost of Indust…Principles of Corporate Finance. (1981)Clinical development success rates for investigational drugs (2014)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Strategic Pricing of New Pharmaceuticals (1998)Trends in development and approval times for new therapeutics in the United States (2003)The Use of Flexible Manufacturing Capacity in Pharmaceutical Product Introductions* (2009)Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents (2018)Stocks, bonds, bills, and inflation yearbook (1993)Risks in new drug development: Approval success rates for investigational drugs (2001)Can the pharmaceutical industry reduce attrition rates? (2004)Conditional logit analysis of qualitative choice behavior (1972)Qualitative Response Models: A Survey (1994)Economic Welfare and the Allocation of Resources for Invention (1962)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)Discovering Addiction (2007)Constructing Regional Advantage: Platform Policies Based on Related Variety and Differentiated Knowledge Bases (2011)Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System? (2012)Lessons from 60 years of pharmaceutical innovation (2009)Spending on new drug development1 (2009)Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)
this work references cited by second hop

References

  • 2003The price of innovation: new estimates of drug development costs4,312 cited
  • 1991Cost of innovation in the pharmaceutical industry763 cited
  • 2007The cost of biopharmaceutical R&D: is biotech different?517 cited
  • 2005The $800 million pill: the truth behind the cost of new drugs133 cited
  • 1980Issues in Pharmaceutical Economics120 cited
  • 2005Extraordinary claims require extraordinary evidence82 cited
  • 2006Are Development Times For Pharmaceuticals Increasing Or Decreasing?54 cited

Cited by

  • 2021Estimating the Cost of Industry Investment in Drug Research and Development: A Review of Methods and Results47 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work